INDIANAPOLIS Leaders of Indiana and Purdue universities Thursday announced the creation of the Indiana Clinical and Translational Sciences Institute (CTSI), a medical research initiative that will combine the strengths of the universities, business and government to swiftly transform discoveries into better patient care and business opportunities.
The National Institutes of Health has awarded a five-year Clinical and Translational Science Award (CTSA) of $25 million to the IU School of Medicine, which will fund CTSI activities at IU and Purdue. A total of $56 million will be invested in the Indiana CTSI by IU and Purdue, the state of Indiana and Eli Lilly and Co., which is underwriting the cost of a senior faculty position for three years.
The NIH created the clinical and translational science awards as a high priority effort to improve the process by which basic science laboratory discoveries are transformed into new medical treatments and products a process called translational research.
The CTSI will implement the NIH initiative in Indiana with new programs to accelerate translational research, train new translational researchers, interact with community health-care professionals and the public, build research resources and technologies, and leverage Hoosier resources with health care, business, government and foundation partnerships.
|Contact: Eric Schoch|